Search

everythinglearnresearchcommunity

for

Search:↓

G allele of AR Stul polymorphism linked to higher hair loss risk, especially in white people.

Some Greek melanoma patients have gene mutations linked to increased cancer risk, a new color feature helps diagnose melanoma, the incidence of a skin condition in the Netherlands is rare, and a gene possibly affects male-pattern baldness.

About 30% of women feel they lose too much hair, often starting before age 40, and most can't find a reason for it.

Chemotherapy improved a girl's painful foot condition linked to pachyonychia congenita.

Caffeine may protect hair follicles from stress-related hair loss.

The document corrected previous errors and announced future dermatology events.

Pellagra, caused by niacin deficiency and presenting with photosensitivity, should be considered in patients with relevant symptoms and risk factors.

The CWARTS tool is a promising method for assessing warts and could improve treatment and research.

We need better research to improve alopecia treatment and patient care.

Eyelashes are important for looks and eye protection, and more people are treating sparse eyelashes; more research is needed to understand eyelash biology and improve treatments.

New hair regrowth model introduced, imiquimod kills skin cancer cells, T-cadherin loss makes skin cancer more invasive, no strong link between PTCH1 gene and skin cancer after transplant, and male teens more likely to have hereditary hair loss.

There are significant gaps and inconsistencies in diagnosing and treating alopecia areata in Greece and Italy.

Delaying hair loss treatment reduces its effectiveness.

Researchers found a genetic link for hereditary hair loss but need more analysis to identify the exact gene.

Many adult women experience unexplained excessive hair shedding, often starting before age 40.

Menopause can cause skin issues, and seeing a dermatologist helps.

New understanding and treatments for hair loss are improving, but more research is needed.

Hair loss from Alopecia Areata is caused by both genes and environment, with several treatments available but challenges in cost and relapse remain.

The document concludes that alopecia areata is an unpredictable autoimmune hair loss condition with no cure, but various treatments exist that require personalized approaches.

There is no significant link between male pattern baldness and insulin resistance.

Alopecia areata can be managed with various treatments, and severe cases should be referred to dermatologists.

Hair loss in male pattern baldness involves muscle degeneration and increased scalp fat.

Certain transporters are found in human hair follicles and may affect hair growth and loss.

Intralesional triamcinolone acetonide can regrow hair in alopecia areata but often has temporary effects and side effects.

Hair thickness matters more than density for baldness in Japanese men over 25.

Platelet-rich plasma treatment significantly increased hair regrowth and decreased discomfort in alopecia patients, making it a potentially better and safer treatment option.

The 2003 guidelines suggest that while some treatments can regrow hair in alopecia areata, none alter the disease's progression, and wigs may be the best option for extensive hair loss.

Bimatoprost solution is effective and safe for long-term use in treating eyelash thinning.

Minoxidil foam 5% effectively treats hair loss in both frontal and vertex scalp regions.

Intense pulsed light treatment mainly damages pigmented hair parts but spares stem cells, allowing hair to regrow.